Next-Gen Immuno-Oncology Conference, 7th-8th March 2024 (London, UK) - One Week to Go
February 28, 2024 04:01 ET
|
Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "8th Annual Next-Gen Immuno-Oncology Conference" has been added to ResearchAndMarkets.com's offering. Leading the Immunotherapy Revolution -...
Global Immuno-oncology Market Projected at $ 396 Billion by 2034 with a 22.94% CAGR; Asia Pacific to Witness Fastest Growth
February 09, 2024 07:42 ET
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering.The global immuno-oncology market size was estimated to be...
Immuno-Oncology Market Poised for Substantial Growth, Driven by Advanced Technologies and Biomarker Integration
January 31, 2024 08:10 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Immuno-oncology Clinical Trials Market Poised for Remarkable Growth, with USD 12.87 Billion Forecasted by 2030
January 24, 2024 08:54 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Clinical Trials Market by Design (Expanded Access Trials, Interventional Trials, Observational Trials), Phase (Phase I, Phase...
Solid Tumor Cancer Treatment Market Anticipates Robust Growth as Innovations and Global Health Challenges Emerge
January 23, 2024 02:53 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Solid Tumor Cancer Treatment Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The latest research publication...
Immunotherapy Advancements: CD40 Agonist and Antagonist Research Fuels Oncology and Autoimmunity Treatment Innovations
December 14, 2023 05:33 ET
|
Research and Markets
Dublin, Dec. 14, 2023 (GLOBE NEWSWIRE) -- The "CD40 Agonists & CD40/L Antagonists Pipeline Review" report has been added to ResearchAndMarkets.com's offering. The global scientific community...
Global Claudin 18.2-Targeted Immunotherapy Landscape Analysis Report 2023: Detailed Profiles of 56 Anti-CLDN18.2 Immunotherapy Candidates
September 22, 2023 04:23 ET
|
Research and Markets
Dublin, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The "Claudin 18.2-Targeted Immunotherapy: A Landscape Analysis of Stakeholders, Drug Modalities, Pipeline and Business Opportunities from An Industry...
Global Oligonucleotide Therapy Markets 2023-2027: Driving Precision Medicine for Targeted Treatment
July 28, 2023 05:33 ET
|
Research and Markets
Dublin, July 28, 2023 (GLOBE NEWSWIRE) -- The "Oligonucleotide Therapy Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The global oligonucleotide therapy...
Advances in Cancer Immunotherapy: Breakthrough Techniques and Key Players Explored in New Report
July 21, 2023 04:53 ET
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer including...
Global Immuno-Oncology Thematic Intelligence Report 2023: Focus on Trends in Bispecific Antibodies, Cancer Vaccines, Cell Therapies, Checkpoint Modulators, Cytokines, & Oncolytic Viruses
June 13, 2023 04:48 ET
|
Research and Markets
Dublin, June 13, 2023 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Thematic Intelligence" report has been added to ResearchAndMarkets.com's offering.This report includes coverage of immuno-oncology...